Fatty Liver and Ectopic Fat in Overweight and Obese Patients
Recruitment status was: Recruiting
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
|Official Title:||Fatty Liver and Ectopic Fat in Overweight and Obese Patients|
- Liver status will be will be determined by liver biopsy, non invasive liver assessment. Biological and medical imaging parameters will be use to characterize our patients. [ Time Frame: at inclusion and at year 1 ] [ Designated as safety issue: No ]
- Non invasive liver assessment, biological and medical imaging parameters will be use to characterize our patients. [ Time Frame: at year 1 ] [ Designated as safety issue: No ]
|Study Start Date:||March 2010|
|Estimated Study Completion Date:||June 2013|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
obese or overweight patients with fatty liver or ectopic fat
Procedure: liver biopsy
Non invasive assessment of liver fibrosis and liver inflammation and steatosis is clinically relevant in patients exposed to non alcoholic fatty liver diseases.
The aim of the study is to find new clinico-biological and medical imaging parameters associated with non alcoholic steatohepatitis in overweight and obese patients.
Fatty liver and ectopic fat accumulation will be particularly assessed.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00886301
|Hepatogastroenterology, Hôpital l'Archet, CHU de Nice|
|Nice, France, 06000|
|Principal Investigator:||Rodolphe ANTY, Dr||Hepatogastroentérology, CHU de Nice|